Boehringer Ingelheim Pharmaceuticals, Inc. Recall: Mobic (meloxicam) tablets, 15 mg, packa
Boehringer Ingelheim Pharmaceuticals, Inc. Recall: Mobic (meloxicam) tablets, 15 mg, packa is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Product: Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer I
| Recalling firm | Boehringer Ingelheim Pharmaceuticals, Inc. |
|---|---|
| Product | Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01 |
| Reason for recall | Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | CO, OH |
| Recall initiated | 20170922 |
| Recall number | D-0007-2018 |
| Category | drug |
| State | CT |
| Country | United States |
$29/mo
Try RecallGuard →